CV Sciences (CVSI) Current Assets (2011 - 2026)
CV Sciences (CVSI) reported Current Assets of $5.0 million for Q1 2026, down 16.23% on a YoY basis from $6.0 million in Q1 2025, and down 2.69% sequentially from $5.1 million in Q4 2025.
CV Sciences (CVSI) Current Assets (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Current Assets data on file, last reported at $5.0 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 16.23% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (down 16.23% YoY), and the FY2025 full-year result was $5.1 million, down 17.78% from the prior year.
- Current Assets eased to $5.0 million in Q1 2026, from $5.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $15.1 million in Q1 2022 to a low of $5.0 million in Q1 2026.
- A 5-year average of $8.2 million and a median of $7.4 million in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets plunged 33.57% in 2023 and declined 11.73% in 2025, its largest moves.
- Tracing CVSI's Current Assets over 5 years: stood at $11.1 million in 2022, then retreated by 28.68% to $7.9 million in 2023, then slipped by 21.35% to $6.2 million in 2024, then decreased by 17.78% to $5.1 million in 2025, then decreased by 2.69% to $5.0 million in 2026.
- Business Quant data shows CVSI's Current Assets at $5.0 million in Q1 2026, $5.1 million in Q4 2025, and $5.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 5.13 Mn |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Dec 31, 2024 | 6.24 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | 6.73 Mn |
| Mar 31, 2024 | 7.35 Mn |
| Dec 31, 2023 | 7.94 Mn |
| Sep 30, 2023 | 8.45 Mn |
| Jun 30, 2023 | 8.55 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Dec 31, 2022 | 11.13 Mn |
| Sep 30, 2022 | 12.20 Mn |
| Jun 30, 2022 | 12.64 Mn |
| Mar 31, 2022 | 15.05 Mn |
| Dec 31, 2021 | 14.19 Mn |
| Sep 30, 2021 | 14.21 Mn |
| Jun 30, 2021 | 15.03 Mn |